Cargando…

Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes

BACKGROUND: Fibroblast growth factor 21 (FGF21), a glucose and lipid metabolic regulator, has recently been demonstrated to be associated with cardiovascular diseases (CVD) such as carotid atherosclerosis, coronary heart disease and carotid artery plaques. However, the relationship between circulati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Yang, Liu, Lingjiao, Xu, Aimin, Zhou, Pengcheng, Long, Zhaofeng, Tu, Yiting, Chen, Xiaoyan, Tang, Weili, Huang, Gan, Zhou, Zhiguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475300/ https://www.ncbi.nlm.nih.gov/pubmed/26047614 http://dx.doi.org/10.1186/s12933-015-0229-9

Ejemplares similares

Fibroblast Growth Factor 19 Levels Predict Subclinical Atherosclerosis in Men With Type 2 Diabetes
por: Hu, Jingyi, et al.
Publicado: (2020)

Circulating Lipocalin-2 and Retinol-Binding Protein 4 Are Associated with Intima-Media Thickness and Subclinical Atherosclerosis in Patients with Type 2 Diabetes
por: Xiao, Yang, et al.
Publicado: (2013)

Sex Modifies the Association of Fibroblast Growth Factor 21 With Subclinical Carotid Atherosclerosis
por: Chee, Yingjie, et al.
Publicado: (2021)

Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
por: Shen, Yun, et al.
Publicado: (2013)

Serum gamma-glutamyltransferase is not associated with subclinical atherosclerosis in patients with type 2 diabetes
por: Yoon, Hye Eun, et al.
Publicado: (2016)

Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
por: Zhang, Xiaoyan, et al.
Publicado: (2015)

Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
por: Jin, Leigang, et al.
Publicado: (2016)

Relation between high serum hepcidin-25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients
por: Yayar, Özlem, et al.
Publicado: (2018)

Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes
por: Aydın, Kadriye, et al.
Publicado: (2016)

Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients
por: Mo, Yifei, et al.
Publicado: (2013)

Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes
por: Hu, Xiang, et al.
Publicado: (2016)

Normal-weight obesity is associated with increased risk of subclinical atherosclerosis
por: Kim, Sohee, et al.
Publicado: (2015)

Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study
por: Chevli, Parag Anilkumar, et al.
Publicado: (2021)

Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
por: Kwok, Kelvin H. M., et al.
Publicado: (2017)

Serum sclerostin level and its relation to subclinical atherosclerosis in the polycystic ovary syndrome phenotypes: A prospective controlled study
por: İncesu Çintesun, Feyza Nur, et al.
Publicado: (2021)

Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes
por: Won, Ki-Bum, et al.
Publicado: (2013)

Associations Between Life-Course Lipid Trajectories and Subclinical Atherosclerosis in Midlife
por: Yan, Yinkun, et al.
Publicado: (2022)

Association of Childhood Oral Infections With Cardiovascular Risk Factors and Subclinical Atherosclerosis in Adulthood
por: Pussinen, Pirkko J., et al.
Publicado: (2019)

Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes
por: Carbonell, Marc, et al.
Publicado: (2018)

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
por: Palanca, Ana, et al.
Publicado: (2019)

Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China
por: Zheng, Tianpeng, et al.
Publicado: (2018)

Serum Endocan Levels and Subclinical Atherosclerosis in Behçet’s Syndrome
por: Nassef, Eman Mostafa, et al.
Publicado: (2022)

Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice
por: Yan, Xiaoqing, et al.
Publicado: (2015)

Therapeutic effects of fibroblast growth factor-21 against atherosclerosis via the NF-κB pathway
por: Zhang, Yiming, et al.
Publicado: (2018)

Long-term effects intensive medical therapy on the development and progression of subclinical atherosclerosis and the metabolic syndrome in Chinese patients with type 2 diabetes mellitus
por: Liu, Zhiwen, et al.
Publicado: (2016)

Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes
por: Colom, Cristina, et al.
Publicado: (2018)

Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death
por: Shen, Yun, et al.
Publicado: (2017)

Sex Differential Genetic Effect of Chromosome 9p21 on Subclinical Atherosclerosis
por: Lin, Hsiu-Fen, et al.
Publicado: (2010)

Decreased serum fibroblast growth factor 19 level is a risk factor for type 1 diabetes
por: Hu, Jingyi, et al.
Publicado: (2021)

Serum fibroblast growth factor 19 is decreased in patients with overt hypothyroidism and subclinical hypothyroidism
por: Lai, Yaxin, et al.
Publicado: (2016)

Exercise Increases Serum Fibroblast Growth Factor 21 (FGF21) Levels
por: Cuevas-Ramos, Daniel, et al.
Publicado: (2012)

Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study
por: Lu, Ya-Wen, et al.
Publicado: (2021)

Serum Fibroblast Growth Factor 21 in Patients with and without Pterygia
por: Yaghoobi, Gholamhosein, et al.
Publicado: (2020)

Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
por: Lin, Zhuofeng, et al.
Publicado: (2015)

Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism
por: Yasar, Hamiyet Yilmaz, et al.
Publicado: (2019)

Relation between Birth Weight, Growth, and Subclinical Atherosclerosis in Adulthood
por: Valente, Maria Helena, et al.
Publicado: (2015)

Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population
por: Aguilera, Eva, et al.
Publicado: (2015)

Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease
por: Oğuz, Didem, et al.
Publicado: (2016)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h90t031jdqnpbudd6jvrb1nc5c